Huan Tran, Head of Finance – R&D Portfolio and Performance at AstraZeneca, shared a post on LinkedIn:
“After an incredibly rewarding four years leading the Oncology Business Unit Global Franchise Finance team, I’m excited to return to my roots in R&D, where I started with AstraZeneca a decade ago. I’ve had the privilege of working with talented colleagues across OBU, seeing firsthand the remarkable growth of the organization, and contributing to work that has made a real difference in patients’ lives.
As I return to R&D Finance, I’m energized by the opportunity to support the teams advancing our industry-leading pipeline and pushing the boundaries of science to bring new medicines to patients.
Many thanks to Kara McNulty and Sunil Verma and my entire team for your partnership and support!”
Other articles about AstraZeneca on OncoDaily.